Cargando…
Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia
SIMPLE SUMMARY: Acute myeloid leukemia is a genetically heterogeneous disease and shows variable treatment outcomes. Genetic profiling has revealed different driver mutations in AML patients. Therefore, it is important to understand the biological impact of these mutations in leukemia transformation...
Autores principales: | Mohanty, Sagarajit, Heuser, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699817/ https://www.ncbi.nlm.nih.gov/pubmed/34944812 http://dx.doi.org/10.3390/cancers13246192 |
Ejemplares similares
-
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
por: Mohanty, Sagarajit, et al.
Publicado: (2020) -
Treatment for Relapsed/Refractory Acute Myeloid Leukemia
por: Thol, Felicitas, et al.
Publicado: (2021) -
Resistance to targeted therapies in acute myeloid leukemia
por: Mecklenbrauck, Rabea, et al.
Publicado: (2022) -
Clinical implications of recurrent gene mutations in acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020) -
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
por: Ochi, Yotaro, et al.
Publicado: (2021)